1-8 of 8
Wolfgang E. Berdel
Close
Sort by
Journal Articles

Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears

Jacqueline Kockwelp, Sebastian Thiele, Jannis Bartsch, Lars Haalck, Jörg Gromoll, Stefan Schlatt, Rita Exeler, Annalen Bleckmann, Georg Lenz, Sebastian Wolf, Björn Steffen, Wolfgang E. Berdel, Christoph Schliemann, Benjamin Risse, Linus Angenendt
Journal: Blood Advances
Blood Adv (2023) 8 (1): 70–79.
https://doi.org/10.1182/bloodadvances.2023011076
Published: 2023
Includes: Supplemental data
Journal Articles

Germline SNPs previously implicated as prognostic biomarkers do not associate with outcomes in intensively treated AML

Clinical Trials & Observations
Aarif M. N. Batcha, Nele Buckup, Stefanos A. Bamopoulos, Vindi Jurinovic, Maja Rothenberg-Thurley, Hanna Gittinger, Bianka Ksienzyk, Annika Dufour, Stephanie Schneider, Mika Kontro, Joseph Saad, Caroline A. Heckmann, Cristina Sauerland, Dennis Görlich, Wolfgang E. Berdel, Bernhard J. Wörmann, Utz Krug, Jan Braess, Ulrich Mansmann, Wolfgang Hiddemann, Karsten Spiekermann, Klaus H. Metzeler, Tobias Herold
Journal: Blood Advances
Blood Adv (2023) 7 (6): 1040–1044.
https://doi.org/10.1182/bloodadvances.2022007988
Published: 2023
Includes: Supplemental data
Journal Articles

Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse

Clinical Trials & Observations
Andrew F. Berdel, Leo Ruhnke, Linus Angenendt, Martin Wermke, Christoph Röllig, Jan-Henrik Mikesch, Annika Scheller, Teresa Hemmerle, Mattia Matasci, Klaus Wethmar, Torsten Kessler, Mirjam Gerwing, Daniel Hescheler, Michael Schäfers, Wolfgang Hartmann, Bianca Altvater, Claudia Rossig, Martin Bornhäuser, Georg Lenz, Matthias Stelljes, Bjoern Rueter, Dario Neri, Wolfgang E. Berdel, Christoph Schliemann
Journal: Blood Advances
Blood Adv (2022) 6 (12): 3684–3696.
https://doi.org/10.1182/bloodadvances.2021006909
Published: 2022
Includes: Supplemental data
Journal Articles

Differential impact of IDH1 / 2 mutational subclasses on outcome in adult AML: results from a large multicenter study

Clinical Trials & Observations
Jan M. Middeke, Klaus H. Metzeler, Christoph Röllig, Michael Krämer, Jan-Niklas Eckardt, Sebastian Stasik, Philipp A. Greif, Karsten Spiekermann, Maja Rothenberg-Thurley, Utz Krug, Jan Braess, Alwin Krämer, Andreas Hochhaus, Tim H. Brümmendorf, Ralph Naumann, Björn Steffen, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Dennis Görlich, Cristina Sauerland, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan W. Krause, Mathias Hänel, Norbert Frickhofen, Richard Noppeney, Ulrich Kaiser, Martin Kaufmann, Desiree Kunadt, Bernhard Wörmann, Katja Sockel, Malte von Bonin, Tobias Herold, Carsten Müller-Tidow, Uwe Platzbecker, Wolfgang E. Berdel, Hubert Serve, Claudia D. Baldus, Gerhard Ehninger, Johannes Schetelig, Wolfgang Hiddemann, Martin Bornhäuser, Friedrich Stölzel, Christian Thiede
Journal: Blood Advances
Blood Adv (2022) 6 (5): 1394–1405.
https://doi.org/10.1182/bloodadvances.2021004934
Published: 2022
Includes: Supplemental data
Journal Articles

A clinically applicable gene expression–based score predicts resistance to induction treatment in acute myeloid leukemia

Clinical Trials & Observations
Christian Moser, Vindi Jurinovic, Sabine Sagebiel-Kohler, Bianka Ksienzyk, Aarif M. N. Batcha, Annika Dufour, Stephanie Schneider, Maja Rothenberg-Thurley, Cristina M. Sauerland, Dennis Görlich, Wolfgang E. Berdel, Utz Krug, Ulrich Mansmann, Wolfgang Hiddemann, Jan Braess, Karsten Spiekermann, Philipp A. Greif, Sebastian Vosberg, Klaus H. Metzeler, Jörg Kumbrink, Tobias Herold
Journal: Blood Advances
Blood Adv (2021) 5 (22): 4752–4761.
https://doi.org/10.1182/bloodadvances.2021004814
Published: 2021
Includes: Supplemental data
Journal Articles

Calcitonin receptor‐like (CALCRL) is a marker of stemness and an independent predictor of outcome in pediatric AML

Clinical Trials & Observations
Linus Angenendt, Marius Wöste, Jan-Henrik Mikesch, Maria Francisca Arteaga, Adrian Angenendt, Sarah Sandmann, Wolfgang E. Berdel, Georg Lenz, Martin Dugas, Soheil Meshinchi, Christoph Schliemann, Claudia Rössig
Journal: Blood Advances
Blood Adv (2021) 5 (21): 4413–4421.
https://doi.org/10.1182/bloodadvances.2021005236
Published: 2021
Includes: Supplemental data
Journal Articles

Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia

Clinical Trials & Observations
Sebastian Stasik, Jan-Niklas Eckardt, Michael Kramer, Christoph Röllig, Alwin Krämer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H. Brümmendorf, Ralph Naumann, Björn Steffen, Volker Kunzmann, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan Krause, Regina Herbst, Mathias Hänel, Norbert Frickhofen, Richard Noppeney, Ulrich Kaiser, Claudia D. Baldus, Martin Kaufmann, Zdenek Rácil, Uwe Platzbecker, Wolfgang E. Berdel, Jiri Mayer, Hubert Serve, Carsten Müller-Tidow, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig, Jan M. Middeke, Christian Thiede, on behalf of the Study Alliance Leukemia (SAL)
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3279–3289.
https://doi.org/10.1182/bloodadvances.2021004631
Published: 2021
Includes: Supplemental data
Journal Articles

Genetic heterogeneity of cytogenetically normal AML with mutations of CEBPA

Nikola P. Konstandin, Friederike Pastore, Tobias Herold, Annika Dufour, Maja Rothenberg-Thurley, Tanja Hinrichsen, Bianka Ksienzyk, Sebastian Tschuri, Stephanie Schneider, Eva Hoster, Wolfgang E. Berdel, Bernhard J. Woermann, Maria C. Sauerland, Jan Braess, Stefan K. Bohlander, Hanns-Georg Klein, Wolfgang Hiddemann, Klaus H. Metzeler, Karsten Spiekermann
Journal: Blood Advances
Blood Adv (2018) 2 (20): 2724–2731.
https://doi.org/10.1182/bloodadvances.2018016840
Published: 2018
Includes: Supplemental data